Gli uccelli delle isole circumsiciliane

Gli autori sintetizzano tutte le informazioni bibliografiche e inedite sulle specie che sino al 30 agosto 2015 sono state contattate almeno una volta nelle 14 isole circumsiciliane (Eolie, Ustica, Egadi, Pantelleria e Pelagie), confrontando alla fine la lista complessiva con quella delle isole Maltesi. In totale sono ad oggi note 434 specie (isole Maltesi incluse); molte di esse hanno mostrato nel corso dei secoli una notevole capacità di colonizzazione, fluttuando nel tempo o addirittura estinguendosi e ricolonizzando alcune isole. Questi piccoli territori in mezzo al mare rappresentano ottimi siti di controllo dell’andamento delle migrazioni nel corso dei decenni; alcune specie hanno chiaramente cambiato il loro status rispetto al passato, aumentando o diminuendo. Nel corso di circa 15 anni in alcune di queste isole (Ustica, Marettimo, Lampedusa e Linosa) sono stati condotti dei campi di inanellamento sia primaverili sia autunnali che hanno permesso di inanellare 102.208 uccelli, in gran parte Passeriformes; ciò ha consentito di raccogliere una notevole mole di dati sulle strategie migratorie, che vengono qui brevemente presentati. Le piccole isole sono davvero importanti per gli uccelli migratori transahariani, che devono sostare durante i loro lunghi viaggi per recuperare energie; la disponibilità di risorse sotto forma di frutti selvatici o di insetti (a seconda delle specie) consente a queste masse di migratori di continuare il loro viaggio. La conservazione degli uccelli è dettata dalla Direttiva Uccelli e l’istituzione delle Zone di Protezione Speciale ha proprio lo scopo di salvaguardare alcune specie in determinati territori. Questo è un impegno preso da parte di tutti i Paesi dell’Unione Europea, proprio perché le popolazioni di uccelli non conoscono confini amministrativi e la loro tutela va al di là delle competenze e degli interessi di un singolo Paese. Per quanto riguarda le specie nidificanti, è risultata un’elevata correlazione negativa (r=-0,746), altamente significativa (P=0,002) tra la capacità dispersiva media delle specie e la superficie in km2 delle isole. Le specie con minore capacità dispersiva hanno colonizzato le isole di maggiori dimensioni, ma non quelle più piccole; questo con molta probabilità dipende dalla eterogeneità ambientale, a sua volta legata alla dimensione delle isole ed alla loro posizione geografica. Nel caso delle isole circumsiciliane, sembra che non sia tanto la distanza dalla costa a determinare il numero di specie, quanto le condizioni ambientali e la posizione geografica; indubbiamente la posizione tirrenica delle isole settentrionali rappresenta un vantaggio per la presenza di habitat differenziati e la conseguente colonizzazione di specie ad essi legate, mentre la posizione meridionale, influenzata dall’aridità africana, riduce alcune possibilità colonizzatrici da parte di alcune specie di uccelli e rende altresì problematica la stessa esistenza di habitat diversificati. Il numero delle specie nidificanti in un’isola è variabile nel tempo, essendovi specie che vi nidificano in modo irregolare. La correlazione area/N° specie nelle isole circumsiciliane è pari a 0,58, ma se si esclude l’isola di Pantelleria, sale a 0,86; essa è pari a 0,92 per le sole isole settentrionali (Eolie, Ustica ed Egadi), mentre risulta 0,99 per le sole tre isole meridionali del Canale di Sicilia.Authors summarize all bibliographic and unpublished information on bird species that have been detected at least one time up to 30th August 2015 in the 14 circum-sicilian islands (Eolian, Ustica, Egadi, Pantelleria and Pelagian Is.). The Appendix 1 compares overall lists with that of the Maltese Is., also lying in the Sicilian waters. On the whole, 434 species are known till now (Maltese Is. included); many of them showed a high colonizing capacity along the centuries, fluctuating or even becoming extinct and re-colonising some islands. These small territories in the middle of the Mediterranean sea are very good check-control sites of long-term migration trend; compared to the past, some species changed their status, increasing or declining. Additionally, during the last 15 years in some of these islands (Ustica, Marettimo, Lampedusa and Linosa) bird ringing activity has been carried out, both in spring and in autumn; it allowed to ring 102,208 birds, mainly Passeriformes; this opportunity allowed to collect a remarkable amount of data on migration strategy, here presented. The small islands are very important stop-over sites for transsaharan migratory birds, that must rest during their long journey to recover fuel in the form of fat; the availability of natural resources, such as wild fruits or insects, allows these masses of migrant birds to continue their trip. The conservation of birds has been established by the Bird Directive and the institution of Zones of Special Protection has the aim to safeguard some species in some territories. This agreement was signed by all countries of the EU, because bird populations do not know administrative borders and their conservation lies beyond the interests and authorities of a single country. Concerning breeding birds, a high negative correlation (r=-0.746, P=0.002) has been found between the average dispersal power of species and the area in km2 of islands. Species with minor dispersal power colonized the biggest but not the smallest islands; this, very probably depended on habitat heterogeneity of islands, in turn linked to the size of them and to the geographical position, more than to the distance from the continental land. Tyrrhenian position of northern islands is certainly an advantage for the presence of diversified habitats and birds inhabiting them, whereas southern position of Pantelleria and Pelagian Is., as well as Maltese Is., affected by African dryness, decreases colonizing probabilities of some bird species and the same existence of diversified habitats. The number of breeding species in each island varied along the time and some species bred irregularly. The correlation area/No. species in the islands surrounding Sicily resulted to be 0.58, but if we exclude Pantelleria Is., it grows to 0.86; besides, it grows to 0.92 if we consider only northern islands (Eolian, Ustica and Egadi Is.), and to 0.99 if we consider only southern islands

Glutamate-evoked redox state alterations are involved in tissue transglutaminase upregulation in primary astrocyte cultures

AbstractThe aim of this study was to evaluate the involvement of oxidative stress in glutamate-evoked transglutaminase (TGase) upregulation in astrocyte cultures (14 DIV). A 24 h exposure to glutamate caused a dose-dependent depletion of glutathione intracellular content and increased the ROS production in cell cultures. These effects were receptor-mediated, as demonstrated by inhibition with GYKI 52466. The pre-incubation with glutathione ethyl ester or cysteamine recovered oxidative status and was effective in significantly reducing glutamate-increased tissue TGase. These data suggest that tissue TGase upregulation may be part of a biochemical response to oxidative stress induced by a prolonged exposure of astrocyte cultures to glutamate

Mediterranean Crossbills Loxia curvirostra sensu lato (Aves, Passeriformes): new data and directions for future research

Mediterranean Crossbills are as much differentiated as L. scotica and L. pytyopsittacus. They are sedentary, linked to pine trees and have evolved a thicker bill to extract the seeds from Pine cones. Their decolorization could be due to dietary causes. The authors studied biometrics, breeding phenology, and primary food of Italian popula tions living in Calabria and Etna (Sicily) and compared them with the other Mediterranean populations. A coevolutive radiation between the different populations of Mediterranean Crossbills presently living in the three main peninsulas, adiacent islands and North Africa occurred separately and this may be demonstrated by their morphometrics, their sedentariness, as well as by songs and some genetic results recently published. They conclude that the same criteria followed to raise L. curvirostra scotica to the species rank as scotica occur also for the dif ferent Mediterranean population

Hydroxyapatite Whiskers Based Resin Composite versus Commercial Dental Composites: Mechanical and Biocompatibility Characterization

A systematic evaluation of mechanical and biocompatibility properties of different volume fractions of hydroxyapatite whiskers in comparison with three commercial dental composites filled with micro- and nanosilica particles was carried out. Six groups with different hydroxyapatite whiskers mass fractions were taken into account in order to be compared with the performances of silica particles based composites group. Flexural properties were evaluated via a universal testing machine (2.5 kN Zwick Line) with a 2 kN load-cell (sensitivity 0.001 N). The test was replicated 10 times for the seven experimental groups to better identify statically the significance of the mechanical performances data. MTT quantitative colorimetric assay was performed in order to evaluate the mitochondrial activity of living cells exposed to different resin composites. Data obtained show better interfacial interaction with filler/matrix until 20 wt% of hydroxyapatite whiskers partially replaced silica particles filler. After this threshold, the mechanical performances decrease dramatically due to both the hydroxyapatite agglomerates formation and the low degree of resin conversion. In addition, biocompatibility test showed less cytotoxic effect with the addition of 20 wt% of hydroxyapatite in comparison with higher rates

Are protected areas covering important biodiversity sites? An assessment of the nature protection network in Sicily (Italy)

GIS spatial analysis of three indicators (vegetation value, faunal richness and landscape heterogeneity) was used to detect and map High-Value Biodiversity Areas (HVBAs), estimate the coverage of biodiversity in the Sicilian protected areas network, and identify new priority areas that could improve long-term biodiversity conservation outcomes. Findings indicated that only 32% of HVBAs are currently covered by the protected areas network. Hotspot analysis revealed that a modest expansion (less than 1%) in the current extent of protected areas would include a disproportionate amount (56%) of biodiversity hotspots, and identified prioritized candidates HVBAs for designation of new protected areas. © 2018 Elsevier Lt

Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study

Background: To verify whether, in patients on metformin (MET) monotherapy for type 2 diabetes (T2D), the add-on of a dipeptidyl peptidase inhibitor (DPP4i) compared to a sulfonylurea (SU) can delay the time to the subsequent treatment intensification (TI). Methods: Population-based administrative data banks from four Italian geographic areas were used. Patients aged ≥18 years on MET monotherapy receiving first DPP4i or SU dispensing between 2008 and 2015 (cohort entry) were followed up to the occurrence of TI (insulin dispensing or add-on of a third non-insulin hypoglicemic >180 days after cohort entry), treatment discontinuation, switch, cancer, death, TI occurrence within, end of data availability, end of study period (31 December 2016), whichever came first. Patients on MET + DPP4i were matched 1:1 with those on MET + SU by sex, age, year of cohort entry, and data bank. Hazard Ratio (HR) and 95% confidence intervals (95%CI) were estimated using multivariable Cox regression model including matching variables and potential confounders measured at baseline. Different sensitivity analyses were performed: i) matching at 180 days after cohort entry, ii) intent to treat (ITT) analysis, iii) matching by duration of MET monotherapy, iv) matching by propensity score. Results: The matched study cohort included 10,600 patients. Overall, 763 TI were observed (4.5/100 person-years; mean follow-up = 1.6 years). The primary analysis showed no difference in time to TI between the two groups (HR = 1.02; 95% CI = 0.88–1.19). Sensitivity analyses confirmed this result, except from the ITT analysis (HR = 1.27; 1.13–1.43). Conclusion: The use of a DPP4i rather than a SU as add-on to MET monotherapy was not associated with a delay in treatment intensification

Covid-19 patient management in outpatient setting: A population-based study from southern italy

Evidence on treatments for early-stage COVID-19 in outpatient setting is sparse. We explored the pattern of use of drugs prescribed for COVID-19 outpatients’ management in Southern Italy in the period February 2020–January 2021. This population-based cohort study was conducted using COVID-19 surveillance registry from Caserta Local Health Unit, which was linked to claims databases from the same catchment area. The date of SARS-CoV-2 infection diagnosis was the index date (ID). We evaluated demographic and clinical characteristics of the study drug users and the pattern of use of drugs prescribed for outpatient COVID-19 management. Overall, 40,030 patients were included in the analyses, with a median (IQR) age of 44 (27–58) years. More than half of the included patients were asymptomatic at the ID. Overall, during the study period, 720 (1.8%) patients died due to COVID-19. Azithromycin and glucocorticoids were the most frequently prescribed drugs, while oxygen was the less frequently prescribed therapy. The cumulative rate of recovery from COVID-19 was 84.2% at 30 days from ID and it was lower among older patients. In this study we documented that the drug prescribing patterns for COVID-19 treatment in an outpatient setting from Southern Italy was not supported from current evidence on beneficial therapies for early treatment of COVID-19, thus highlighting the need to implement strategies for improving appropriate drug prescribing in general practice

Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study

Background Since 2007 biosimilars of erythropoiesis-stimulating agents (ESAs) are available on the Italian market. Very limited post-marketing data exist on the comparative effectiveness of biosimilar and originator ESAs. Aim This population-based study was aimed to compare the effects of biosimilars, reference product and other ESAs still covered by patent on hemoglobinemia in chronic kidney disease (CKD) and cancer patients in a Local Health Unit (LHU) from Northern Italy. Methods A retrospective cohort study was conducted during the years 2009-2014 using data from Treviso LHU administrative database. Incident ESA users (no ESA dispensing within 6 months prior to treatment start, i.e. index date (ID)) with at least one hemoglobin measurement within one month prior to ID (baseline Hb value) and another measurement between 2nd and 3rd month after ID (follow-up Hb value) were identified. The strength of the consumption (as total number of defined daily dose (DDD) dispensed during the follow-up divided by days of follow-up) and the difference between follow-up and baseline Hb values [delta Hb (ΔHb)] were evaluated. Based on Hb changes, ESA users were classified as non-responders (ΔHb≤0 g/dl), responders (0Delta;Hb≤2 g/dl), and highly responders (ΔHb>2 g/ dl). A multivariate ordinal logistic regression model to identify predictors for responsiveness to treatment was performed. All analyses were stratified by indication for use and type of dispensed ESA at ID. Results Overall, 1,003 incident ESA users (reference product: 252, 25.1%; other ESAs covered by patent: 303, 30.2%; biosimilars: 448, 44.7%) with CKD or cancer were eligible for the study. No statistically significant difference in the amount of dose dispensed during the follow-up among biosimilars, reference product and other ESAs covered by patent was found in both CKD and cancer. After three months from treatment start, all ESAs increased Hb values on average by 2g/dl. No differences in ΔHb as well as in frequency of non-responders, responders and highly responders among different types of ESAs were observed in both indications of use. Overall, around 15-20% of ESA users were non-responders. Strength of treatment, but no type of dispensed ESAs was found to be predictor of responsiveness to treatment. Conclusions No difference on the effects on hemoglobinemia among users of either biosimilars or reference product or ESAs covered by patent was observed in a general population from Northern Italy, despite a comparable dispensed dose of the different ESAs during the first three months of treatment

Cytosolic Guanine Nucledotide Binding Deficient Form of Transglutaminase 2 (R580a) Potentiates Cell Death in Oxygen Glucose Deprivation

Transglutaminase 2 (TG2) is a hypoxia-responsive protein that is a calcium-activated transamidating enzyme, a GTPase and a scaffolding/linker protein. Upon activation TG2 undergoes a large conformational change, which likely affects not only its enzymatic activities but its non-catalytic functions as well. The focus of this study was on the role of transamidating activity, conformation and localization of TG2 in ischemic cell death. Cells expressing a GTP binding deficient form of TG2 (TG2-R580A) with high basal transamidation activity and a more extended conformation showed significantly increased cell death in response to oxygen-glucose deprivation; however, targeting TG2-R580A to the nucleus abrogated its detrimental role in oxygen-glucose deprivation. Treatment of cells expressing wild type TG2, TG2-C277S (a transamidating inactive mutant) and TG2-R580A with Cp4d, a reversible TG2 inhibitor, did not affect cell death in response to oxygen-glucose deprivation. These findings indicate that the pro-cell death effects of TG2 are dependent on its localization to the cytosol and independent of its transamidation activity. Further, the conformational state of TG2 is likely an important determinant in cell survival and the prominent function of TG2 in ischemic cell death is as a scaffold to modulate cellular processes

How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010-2016

Purpose: To describe intravitreal anti-VEGF drug and dexamethasone use in four Italian regions.Methods: Four regional claims databases were used to measure drug prevalence, compare dosing intervals to those recommended in the summary of product characteristics (SPC), and identify switchers. Bilateral treatment and diabetic macular edema (DME) coding algorithms were validated, linking claims with a sample of prospectively collected ophthalmological data.Results: Overall, 41,836 patients received 651 study drug in 2010-2016 (4.8 per 10,000 persons). In 2016, anti-VEGF drug use ranged from 0.8 (Basilicata) to 5.7 (Lombardy) per 10,000 persons while intravitreal dexamethasone use ranged from 0.2 (Basilicata) to 1.4 (Lombardy) per 10,000 persons. Overall, 40,815 persons were incident users of study drugs. Among incident users with 651 year of follow-up (N = 30,745), 16.0% (N = 30,745), 16.0% (N = 30,745), 16.0% (.Conclusion: Study drug use increased over time in Lombardy, Basilicata, Calabria, and Sicily, despite a large heterogeneity in prevalence of use across regions. Drug treatment appeared to be partly in line with SPC, suggesting that improvement in clinical practice may be needed to maximize drug benefits